Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Copeinca is a leading global producer of fishmeal and fish oil, headquartered in Lima, Peru. The company specializes in the processing of anchoveta (Engraulis ringens) to extract high-quality proteins and Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). These products are essential raw materials for the pharmaceutical and nutraceutical industries, supporting the production of cardiovascular health supplements and lipid-regulating medications. Copeinca operates several state-of-the-art processing plants and maintains its own fishing fleet to ensure a vertically integrated supply chain. In 2013, the company was acquired by China Fishery Group, further expanding its reach in the global nutrition market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Copeinca.